About
Basic Data Updated:
25 days agoPharmaceuticals and medical devices are developed, manufactured, and marketed by Fresenius Kabi India Private Limited. A wide range of infusion therapy products, including basic solutions, infusion solutions for osmotic therapy, irrigation solutions/urology, infusion solutions for blood volume replacement and hemodilution therapy, medical devices, infusion and clinical fluid management systems, are provided by the company. Additionally, FKIPL offers par-enteral nutrition products, immune modulation products, enteral products, oral amino keto acids, medical devices, filter systems, and oncology products. These products are used in various therapeutic areas such as blood volume substitution, infusion therapy, clinical nutrition, transfusion technology, enteral nutrition, fluid management, anesthesia, critical illness, oncology, liver insufficiency, and renal insufficiency, and are available worldwide. The production facilities of FKIPL are located in Ranjangaon, Pune, and Goa, ensuring efficient and timely delivery of high-quality products. The company also has branches in Pune and Mumbai, providing easy access to its products and services for customers. With a strong focus on research and development, FKIPL continuously strives to innovate and improve its products to meet the evolving needs of the healthcare industry.
Industry
Company Details
- Location
Pune, Maharashtra, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U24231PN1995PTC014017 |
| Company No. | 014017 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 02 Feb 1995 |
| Date of AGM | 29 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Pune |
Products or Services related to Fresenius Kabi India Private Limited
Blood Bank Equipments
Medical Pumps
Syringe Pump
Corona Test Kit
Financials of Fresenius Kabi India Private Limited
Fresenius Kabi India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 42.46% increase. The company also saw a substantial fall in profitability, with a 98.66% decrease in profit. The company's net worth observed a substantial decline by a decrease of 26.01%.
Corporate Structure
Unlock access to Fresenius Kabi India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Fresenius Kabi India Private Limited
Unlock and access historical data on people associated with Fresenius Kabi India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
Sanjay Gupta
Managing DirectorAppointment Date: 10-Jul-2009
Status: Current
Kaushal Gupta CFOAppointment Date: 30-Sep-2019
Status: Current
SS
Sayali Shrotri Company SecretaryAppointment Date: 30-Jun-2023
Status: Current
Board Members(4)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 26 Jul 2004 | ₹1.70 Cr | Open |
State Bank Of India Creation Date: 09 May 1997 | ₹2.70 Cr | Open |
Abn Amro Bank N.V. Creation Date: 26 May 2003 | ₹11.00 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fresenius Kabi India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fresenius Kabi India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Recent activity within the organization
Annual General Meeting
Fresenius Kabi India Private Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.
29 Sep 2023Balance Sheet
Fresenius Kabi India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Pune.
31 Mar 2023Director Appointment
Prakash Sahebrao Patil was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 31 Jan 2022 & has been associated with this company since 2 years 3 months .
31 Jan 2022Director Appointment
Hanno Michael Diehl was appointed as a Director was appointed as a Director on 28 Jun 2019 & has been associated with this company since 4 years 10 months .
28 Jun 2019Director Appointment
Kaushal Devendra Gupta was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 25 Sep 2014 & has been associated with this company since 9 years 7 months .
25 Sep 2014
Recent News, Updates & Announcement
Akorn Comments on Favorable Court Order.GlobeNewswire 01 Mar 2019
- India Large Volume Parenteral LVP Market 20182025 with Fresenius Kabi Baxter Otsuka Pharmaceutical and BML Parenteral Drugs Dominating.
PRNewswire The quotIndia Large Volume Parenteral LVP Market Analysis Report By Volume By Application Therapeutic Injections Fluid Balance Injections.
PR Newswire 20 Nov 2018
Frequently asked questions
What is the Incorporation or founding date of Fresenius Kabi India Private Limited?
